Temple Therapeutics BV
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.templerx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions
Phase 1
Completed
- Conditions
- Pelvic Adhesions
- Interventions
- Drug: Physiologic salineDrug: L-Alanyl/L-Glutamine
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Temple Therapeutics BV
- Target Recruit Count
- 47
- Registration Number
- NCT01701193
- Locations
- 🇺🇦
8Surgery and Endoscopy Department of Kharkiv Medical Academy of Postgraduate Education Kharkiv City Clinical Multi-field Hospital, Kharkiv, Ukraine
News
No news found